Search results

Page results

• Introduction to the Lymphoedema Service: Face-to-face consultation

  This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.

• Peripherally inserted central catheters (PICCs)

  This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).

• Sperm banking - Information for teenagers and young adults with a cancer diagnosis

  This page explains what sperm banking is, how it works and how it can benefit you.

• Improving clinic attendance and reducing health inequalities in children and young people

  A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.

• New surgical technique preserves continence in men after prostate removal

  A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Information for carers of children or young people having mIBG treatment

  This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.